Tech giants like Alibaba and Tencent invest in AI startups like DeepSeek not just for financial returns, but for strategic benefits. The investment helps them acquire the startup as a cloud computing customer and secures access to its cutting-edge technology for their own massive user bases.

Learning from the struggles of Alibaba and Tencent, a new generation of Chinese AI companies will proactively establish headquarters in neutral hubs like Singapore. This strategy is designed to shed their identity as purely "Chinese tech," making them more palatable for global markets, acquisitions, and IPOs.

The investment thesis for new AI research labs isn't solely about building a standalone business. It's a calculated bet that the elite talent will be acquired by a hyperscaler, who views a billion-dollar acquisition as leverage on their multi-billion-dollar compute spend.

Private AI companies in China, like DeepSeek, are justifying multi-billion dollar valuations by pointing to publicly traded peers. Companies like Minimax and Zipu, which IPO'd under $10B, now trade at $30-50B, setting a new, much higher valuation precedent for private funding rounds, even with limited revenue.

Pre-product AI startups are commanding billion-dollar valuations because the barrier to entry has skyrocketed. To build a competitive new foundation model, a startup must be able to raise approximately $2 billion before even launching a product. This forces VCs to place massive, early bets on a very small number of elite, pedigreed founders.

AI startup Manus's move from China to Singapore was a survival tactic to escape a market where big tech clones viral products in days. This strategic relocation allowed it to build defensible traction with a Western user base, creating a new playbook for Chinese-founded startups seeking global acquisition.

An explosion of billion-dollar valuations has created more unicorns than the pool of strategic buyers can support. This problem is worse for AI startups, whose massive valuations often exceed those of the legacy players they disrupt, making acquisition by their most logical buyers impossible and forcing a reliance on a tight IPO market.

Small, independent AI labs ("Neo-labs") are not genuine competitors to frontier players like OpenAI. Instead, they serve as a career interlude for high-profile researchers. These individuals can raise capital, enjoy a secondary liquidity event, and work on passion projects before ultimately being re-absorbed into a major lab.

For AI giants with billions in capital, elite talent is far more valuable and scarce than money. Acquiring a promising YC startup is a highly efficient way to recruit a top-tier team. This M&A dynamic underpins the seemingly irrational, sky-high valuations for early-stage AI companies.